Immpact Bio Usa
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4010 Adolfo Rd, Camarillo, California, 9...Phone Number
(805) 437-9706Website
www.immpact-bio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Immpact Bio Usa
Founded in 2017 and headquartered in Camarillo, California, ImmPACT Bio is developing logic-gate-based CAR T platforms that address key challenges for current cell therapies in oncology.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immpact Bio Usa your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Immpact Bio Usa, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Immpact Bio Usa is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Immpact Bio Usa
Product Launch: Get notified when Immpact Bio Usa launches new products
Earning: See what the market has to say on Immpact Bio Usa recently announced quarterly report
Funding: Get notified immidiatlly once Immpact Bio Usa has new funding data
Check if Immpact Bio Usa has recently received funding, and reach out quickly before it becomes old news!
Click to see if Immpact Bio Usa had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Immpact Bio Usa as Masked Content
Find more new buyers
Compare Similar Companies to Immpact Bio Usa
Compare insights from companies similar to Immpact Bio Usa, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immpact Bio Usa
<$5M
11-50
Private
-
2020
N/A
Company Profile Activity
Activity Insights
Immpact Bio Usa is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Immpact Bio Usa is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Immpact Bio Usa.
Immpact Bio Usa Tech Stack
A closer look at the technologies used by Immpact Bio Usa
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Promotion
Executive Move
Immpact Bio Usa has announced that Sumant Ramachandra has been promoted from President & Chief Executive Officer to the role of Chief Executive Officer & Board Director.
New Hire
Executive Move
Project
Product Management, Intellectual Property, Legal Affairs
Left Company
Executive Move
Immpact Bio Usa News & Media
ImmPACT Bio to Participate at the 2024 Cell and Gene Meeting on the Mesa Conference
LOS ANGELES, Sept. 25, 2024 /PRNewswire/ -- ImmPACT Bio USA, Inc. ("ImmPACT Bio"), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer and autoimmune diseases, today announced that it will participate at...ImmPACT Bio Announces FDA Clearance of IND Application for CD19/CD20 Bispecific CAR-T Cell Therapy in Multiple Sclerosis
IMPT-514 is the first-and-only known CD19/CD20 CAR T-cell therapy in development for multiple sclerosis Dual CD19/CD20 targeting is designed to enable broad depletion of pathogenic autoimmune cells Initiation of Phase 1 dose exploration trial expected first half of 2025 LOS ANGELES, Aug....ImmPACT Bio Appoints Ian Somaiya to its Board of Directors
/PRNewswire/ -- ImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the...ImmPACT Bio to Present New Preclinical Data for CD19/CD20 Bispecific CAR-T Cell Therapy in Multiple Sclerosis
IMPT-514's dual CAR approach is designed to ablate B-cells and pathogenic CD20+ T cells for potential therapeutic benefit in MS LOS ANGELES, May 21, 2024 /PRNewswire/ -- ImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immpact Bio Usa
Sign Up For FreeTo access detailed company insights
Founded in 2017 and headquartered in Camarillo, California, ImmPACT Bio is developing logic-gate-based CAR T platforms that address key challenges for current cell therapies in oncology.... Read More
